OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER

NCT01050114 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: onaBoNT-A
DRUG: Oxybutynin ER

Sponsor

Christopher Patrick Smith